Celgene
Global biopharmaceutical company focused on discovering, developing and delivering prescription medicines across oncology, immunology, hematology and cardiovascular disease. Operates worldwide with research and development centered on causal human biology, diverse therapeutic modalities, translational medicine and efforts to accelerate clinical proof of concept and patient access.
Industries
Nr. of Employees
small (1-50)
Celgene
Products
Commercial portfolio of prescription medicines
A global portfolio of prescription medicines across oncology, immunology, hematology and cardiovascular disease supported by prescribing information and regulatory risk-management materials.
Commercial portfolio of prescription medicines
A global portfolio of prescription medicines across oncology, immunology, hematology and cardiovascular disease supported by prescribing information and regulatory risk-management materials.
Services
End-to-end clinical trial operations and a digital trial-matching platform for researchers and patients.
Medical information response services and resources for healthcare professionals and patients, including global contact centers.
Global adverse event monitoring and reporting, product quality complaint handling and safety governance.
Patient assistance, coverage navigation, translation services and educational resources to support medicine access and adherence.
Funding for continuing medical education, rotations and scientific meetings to support professional development.
End-to-end clinical trial operations and a digital trial-matching platform for researchers and patients.
Medical information response services and resources for healthcare professionals and patients, including global contact centers.
Global adverse event monitoring and reporting, product quality complaint handling and safety governance.
Patient assistance, coverage navigation, translation services and educational resources to support medicine access and adherence.
Funding for continuing medical education, rotations and scientific meetings to support professional development.
Expertise Areas
- Clinical trial management
- Pharmacovigilance and drug safety
- Translational medicine
- Cell therapy development
Key Technologies
- Cell therapy (CAR-T)
- Targeted protein degradation
- Radiopharmaceutical development
- Advanced small-molecule chemistry
News & Updates
Article describing the company's work in lung cancer research and patient outcomes.
Article about programs to improve cardiovascular care in rural communities.
Recent press releases and regulatory updates, including product approval and trial results.
Reported investment of $9.3 billion in research and development for 2023.
Article describing the company's work in lung cancer research and patient outcomes.
Article about programs to improve cardiovascular care in rural communities.
Recent press releases and regulatory updates, including product approval and trial results.
Reported investment of $9.3 billion in research and development for 2023.